1                                              Budd-Chiari syndrome (BCS) and portal vein thrombosis ha

2                                              Budd-Chiari syndrome (BCS) is a rare condition associate

3                                              Budd-Chiari syndrome (BCS) is a rare, life-threatening d

4                                              Budd-Chiari syndrome (BCS) is uncommon in the children.

5                                              Budd-Chiari Syndrome (BCS) results from obstruction to h

6                                              Budd-Chiari syndrome, occlusion or obstruction of hepati

7 flow obstruction, which presents as an acute Budd-Chiari syndrome.

8                    Either acute or sub-acute Budd-Chiari syndrome (BCS) with diffuse occlusion of hep

9 an lead to hepatic congestion, cirrhosis and Budd-Chiari syndrome (BCS) and can predispose to develop

10 atichydrothorax, portal vein thrombosis, and Budd-Chiari syndrome.

11 e described in the context of heart disease, Budd-Chiari syndrome, and the sinusoidal obstruction syn

12 ngs included hepatofugal portal venous flow, Budd-Chiari syndrome, cavernous transformation of the po

13 o orthotopic liver transplantation (OLT) for Budd-Chiari syndrome (BCS) traditionally have been antic

14       TIPS has also been used as therapy for Budd-Chiari syndrome and veno-occlusive disease.

15 ic and portal veins, resulting in functional Budd-Chiari syndrome and portal hypertension.

16 eoplasms (MPNs) are the most common cause of Budd-Chiari syndrome (BCS) and nonmalignant, noncirrhoti

17 ive disorders (MPDs) are a frequent cause of Budd-Chiari syndrome (BCS), treatment directed toward al

18 e patient died at 1 month from tumor-related Budd-Chiari syndrome.

19      Giant invalidating tumor (5 HAS, 1 with Budd-Chiari syndrome [BCS], and 10 supposed epithelioid

20 dical records of all patients diagnosed with Budd-Chiari syndrome at the Johns Hopkins Hospital durin

21 ic shunt (TIPS) in a series of patients with Budd-Chiari syndrome (BCS), and to determine the predict

22                             In patients with Budd-Chiari syndrome and with portal vein thrombosis, Ki